HGHVX Mutual Fund

NAV$51.48

Fund Essentials - as of Jan 31, 2026

Net Assets
$7M
Expense Ratio
0.92%
Dividend Yield (Current)
2.71%
Holdings
84
Inception Date
Feb 28, 2019
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.21%
1 Year+32.57%
3 Year+8.71%
5 Year+5.29%

Asset Allocation

Stocks: 99.68%
Bonds: 0.19%
Cash: 0.14%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co13.12%
MRKMerck & Company Inc5.74%
JNJJohnson & Johnson5.07%
UNHUnitedhealth Group Incorporated4.64%
ABBVAbbvie Inc.3.84%
Top 10 Concentration: 47.48%Report Date: Jan 31, 2026
Download all 84 holdings for HGHVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.71%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how HGHVX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

HGHVX Mutual Fund Overview

HGHVX Mutual Fund (The Hartford Healthcare Fund Class R6) is managed by Hartford Funds with $6.7M in net assets. HGHVX expense ratio is 0.92%, holding 84 positions across sectors including Health Care, Unknown, Financials. Inception date: 2019-02-28.

HGHVX performance shows a YTD return of 5.21%. The 1-year return is 32.57% and the 5-year return is 5.29%. HGHVX dividend yield stands at 2.71%, paid annually.

HGHVX top holdings include Eli Lilly & Co (13.1%), Merck & Company Inc (5.7%), Johnson & Johnson (5.1%), Unitedhealth Group Incorporated (4.6%), Abbvie Inc. (3.8%). View all HGHVX holdings, sector breakdown, or dividend history.

HGHVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHVX alternatives are available via the screener, along with tax-loss harvesting opportunities.